Labcorp Holdings Inc. (LH) Stock Analysis

72.0/100
Buy Not Halal Healthcare
Price $259.93
Market Cap $22.61B
Change +7.46%

Is LH a good investment?

Labcorp Holdings Inc. (LH) has a Plutrex AI rating of 72.0/100 as of May 26, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Exceptional operational efficiency with 10.6% operating margin vs industry losses of -0.62%. Main concern: Growth deceleration from 12.8% historical to 8.3% forward EPS growth with PEG 1.65 indicating overvaluation.

Investment Summary

LH presents a mixed investment case with exceptional operational efficiency (Operating Margin 10.6% vs industry -0.62%) and strong cash generation ($966.6M free cash flow) but concerning growth deceleration. PE ratio of 26.22 appears elevated for 8.3% forward EPS growth, creating PEG of 1.65 (overvalued). However, trades at 86.7% discount to industry PE (26.22 vs 197.51), making it relatively attractive. Recent positive news including strategic appointments and partnerships supports near-term sentiment with 96/100 news score.

Key Strengths

Key Concerns

Plutrex 10-Factor AI Breakdown

Financial Health
80/100
Growth Potential
55/100
Valuation
75/100
Profitability
85/100
Debt Management
78/100
Analyst Sentiment
85/100
Technical Momentum
70/100
Insider Confidence
65/100
News Sentiment
96/100

Fundamental Analysis

Strong operational metrics with ROE 10.5% and superior profitability (Net Margin 6.3% vs industry -8.87%). Debt-to-Equity 0.68 is manageable with $532.3M cash providing adequate liquidity. Critical concern: growth deceleration from historical 12.8% EPS growth to projected 8.3% next year and 8.6% five-year forward growth. PEG ratio 1.65 indicates overvaluation, though PE 26.22 trades at massive discount to industry average 197.51. Free cash flow $966.6M demonstrates strong cash generation capability.

News Sentiment

Laboratory Corporation of America is navigating a period of strategic transformation while maintaining its position as a diagnostics industry leader. Recent developments paint a picture of measured optimism as the company prepares for its Q1 earnings report. The appointment of Christine Oliver as President at d-wise, a Labcorp partner, signals continued investment in growth initiatives and strategic partnerships. Meanwhile, analyst sentiment has been improving with rating upgrades to 'Buy,' suggesting Wall Street sees value in the company's current positioning. The company has also strengthened its collaborative network, announcing a new partnership with Children's Hospital of Philadelphia to accelerate pediatric research capabilities. Additionally, Labcorp's commitment to shareholder returns remains evident through its quarterly dividend declaration. These developments come as the healthcare diagnostics sector continues evolving, with companies like Labcorp balancing traditional testing services with emerging digital health solutions. While the company faces growth challenges compared to industry peers, its operational excellence and strategic partnerships position it as a stable player in the evolving healthcare landscape. Investors are watching closely to see if management's strategic initiatives can reignite growth momentum.

Risk Assessment

Primary risk is growth deceleration trend continuing, making current valuation unsustainable. Industry disruption from new diagnostic technologies could pressure margins. Positive: strong balance sheet and cash flow provide downside protection, while defensive healthcare exposure offers recession resilience.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is LH a halal stock?

No, Labcorp Holdings Inc. (LH) is currently not classified as halal by AAOIFI criteria.

What is Plutrex's AI rating for LH?

Labcorp Holdings Inc. (LH) has a Plutrex AI rating of 72.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is LH a good investment?

According to Plutrex AI, LH has a Buy rating (72.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in LH?

US stocks like LH can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in LH?

Plutrex AI identifies the main risks for LH by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with Plutrex AI about LH

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open LH in Plutrex